National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

dactinomycin
A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus. Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:ACT-D
actinomycin C1
actinomycin D
actinomycin I1
actinomycin IV
actinomycin X 1
actinomycin-[thr-val-pro-sar-meval]
AD
dactinomycine
meractinomycin
US brand names:Cosmegen
Lyovac Cosmegen
Abbreviation:DACT
Chemical structure name:2-bis[cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3



Previous:DAB389 epidermal growth factor, dacarbazine, dacetuzumab, daclizumab, Dacogen
Next:dalteparin, danazol, daniquidone, Danocrine, daptomycin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov